z-logo
Premium
Strong Inhibition of Beta‐Amyloid Peptide Aggregation Realized by Two‐Steps Evolved Peptides
Author(s) -
Ghimire Gautam Sunita,
Komatsu Masayuki,
Nishigaki Koichi
Publication year - 2015
Publication title -
chemical biology and drug design
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 77
eISSN - 1747-0285
pISSN - 1747-0277
DOI - 10.1111/cbdd.12400
Subject(s) - peptide , thioflavin , in vitro , amyloid beta , chemistry , amyloid (mycology) , cytotoxic t cell , biochemistry , protein aggregation , beta (programming language) , alzheimer's disease , biophysics , disease , biology , medicine , pathology , inorganic chemistry , computer science , programming language
Several decades of cumulated research evidence have proven that aggregation of beta‐amyloid 42 (A β 42) is the main cause of neuronal death in the brains of patients with Alzheimer's disease. Therefore, inhibition of A β 42 aggregation holds great promise for the prevention and treatment of Alzheimer's disease. To this end, we used a systematic in vitro evolution including a paired peptide library method. We identified two peptides with high binding affinity (with K d in the n m range) for A β 42. Functionally, these peptides strongly inhibited the aggregation of A β 42 as shown by the thioflavin T assay and atomic force microscopy. Moreover, these peptides rescued PC 12 cells from the cytotoxic effect of aggregated A β 42 in vitro . Our results suggest that these novel peptides may be potential therapeutic seeds for the treatment of Alzheimer's disease.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here